Heart failure clinicsM.Kamran Baig,Niall Mahon,William J. McKenna,Alida L.P. Caforio,Robert O. Bonow,Gary S. Francis,Mihai Gheorghiade.The pathophysiology of advanced heart failure[J]. American Heart Journal .1998(6)The pathophysiology of advanced heart failure[J] . M.Kamran Baig,Niall ...
The introduction of multiple new pharmacological agents over the past three decades in the field of heart failure with reduced ejection fraction (HFrEF) has led to reduced rates of mortality and hospitalizations, and consequently the prevalence of HFrEF has increased, and up to 10% of patients pro...
Abnormal cardiac metabolism contributes to the pathophysiology of advanced heart failure with reduced left ventricular ejection fraction (LVEF). Glucagon-like peptide 1 (GLP-1) agonists have shown cardioprotective effects in early clinical studies of patients with advanced heart failure, irrespective of ty...
Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep. 2000;2(3):198-205. doi:10.1007/s11886-000-0069-3 PubMedGoogle ScholarCrossref 16. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M. Possibility...
Other patients with a biventricular circulation and subaortic LV have a pathophysiology in which LV dysfunction is primarily VAD in Patients With a 2V-RV Today, patients with failing 2V-RV circulations are one of the larger subgroups of ACHD-HF (Figure 2, Figure 7 and 7). The majority ...
Abnormal cardiac metabolism contributes to the pathophysiology of advanced heart failure with reduced left ventricular ejection fraction (LVEF). Glucagon-l... KB Margulies,AF Hernandez,MM Redfield,... - 《Jama》 被引量: 62发表: 2016年 Phase II Feasibility and Pharmacokinetic Study of Concurrent Adm...
Cardiac - Heart Failure & Shock_ Par 2016-05-08 16:18:3116:59 134 所属专辑:Advanced Clinical Pathophysiology 喜欢下载分享 声音简介Advanced Clinical Pathophysiology 用户评论 表情0/300发表评论 暂时没有评论,下载喜马拉雅与主播互动音频列表 1 Cardiac - Heart Failure & Shock_ Par 1 1922016-05 2 ...
Immunological processes are implicated in the multifactorial pathophysiology of heart failure (HF). The multifunctional chemokine fractalkine (CX3CL1) promotes the extravasation of cytotoxic lymphocytes into tissues. We aimed to assess the prognostic value of fractalkine in HF. Fractalkine plasma levels we...
Abstract. Background: Use of inotropic agents in advanced heart failure (HF) has over time been evaluated in several randomized, controlled clinical
Patients’ perceptions of illness severity in advanced heart failure. J Hosp Palliat Nurs 2016; 18(2): 110–114 Article Google Scholar Katz AM, Konstam MA (2009) Heart failure: pathophysiology, molecular biology and clinical management, 2nd edn. Lippincott, Williams & Wilkens, Philadelphia. 335...